Key takeaways
Trelegy Ellipta is a once-daily prescription drug used to treat COPD—including chronic bronchitis and emphysema—as well as asthma.
Without insurance coverage or discounts, Trelegy Ellipta can cost around $872 per month.
Many insurance and Medicare plans cover Trelegy Ellipta, but the out-of-pocket costs depend entirely on the provider and plan.
The GSK patient assistance program makes it possible for eligible applicants to receive Trelegy Ellipta for free.
Other cost-saving methods include applying for a Trelegy Ellipta copay card and using a SingleCare Trelegy coupon.
Chronic obstructive pulmonary disease (COPD) affects 11.7 million Americans, and asthma affects 24.8 million Americans, according to the American Lung Association. And, for many of those people, Trelegy Ellipta could be a viable treatment option. As a combination of fluticasone, umeclidinium, and vilanterol, this once-daily prescription drug is approved by the Food and Drug Administration (FDA) to treat the symptoms of asthma and COPD, which includes emphysema and bronchitis. It can be expensive, but patients have options for reducing their out-of-pocket costs, including the Trelegy Ellipta patient assistance program.
How much does Trelegy cost?
Without assistance from insurance, discounts, or other programs, Trelegy Ellipta costs an average of $872 per 60-use aerosol powder inhaler. Of course, that price can vary depending on the pharmacy, dosage, and more. In fact, drug prices can vary by hundreds of dollars between pharmacies, so the price you pay could be much lower or higher than the average.
Trelegy patient assistance program
Not everyone has the benefit of commercial insurance, Medicare, or Medicaid coverage, but that doesn’t mean that they’re out of luck. “While Trelegy can be expensive, patients have options to manage costs effectively, such as exploring assistance programs, considering generic alternatives, and leveraging insurance coverage,” says Jung Baccam, FNP-BC, a nurse practitioner at Atlas Ketamine. “Collaboration with healthcare providers and insurers is crucial for identifying cost-saving strategies.”
The manufacturer of Trelegy Ellipta, GSK, offers a patient assistance program for certain uninsured patients or those on Medicare. Anyone who qualifies can receive Trelegy Ellipta at no cost. To qualify, patients must:
- Live in the United States or Puerto Rico
- Be uninsured or on Medicare
- Meet income criteria
- Not be enrolled in any alternative funding programs.
Eligible patients can enroll by completing an enrollment application and sending it to the fax number or address on the application.
Patients can also enroll by phone if they need their medication immediately. To do so, there are a few steps that their healthcare provider needs to take:
- Call the GSK patient assistance program at 866‑728‑4368 to see whether their patient is eligible for the medication immediately.
- If the patient is eligible, fax the completed application with all required signatures to 855-474-3063.
- Once received and approved, GSK will provide the healthcare provider with the information to provide the patient’s retail pharmacy for an immediate fill. The patient can pick up the medication that day at their chosen pharmacy.
Eligible patients will get refills at no cost for up to 12 months after enrolling in the program.
Other ways to save on Trelegy Ellipta
If you have private health insurance or don’t qualify for the Trelegy Ellipta patient assistance program, there are other ways you may save on your medication.
Trelegy copay card
Uninsured patients aren’t the only ones who might find it difficult to pay for Trelegy. Sometimes, private health insurance plans won’t cover the full cost. Fortunately, there’s a savings card option that may help. In order to be eligible, you need health insurance that covers some of the cost of Trelegy Ellipta and you cannot be enrolled in Medicare, Medicaid, or other government-funded assistance programs.
The maximum that this card will cover is $500 per month between January 1 and March 31, and $200 per month at all other times. These savings only last for 12 uses, with each 30-day supply counting as one use.
SingleCare prescription savings card
SingleCare has negotiated directly with pharmacies to get members discounts on prescription drugs like Trelegy Ellipta. All you have to do is sign up for free and present the prescription discount card at your chosen pharmacy. You can currently save up to $350 on Trelegy Ellipta, depending on your pharmacy.
Anyone can use SingleCare, even individuals who have private insurance or Medicare. However, you have to use either SingleCare discounts or insurance coverage, but not both. People whose insurance covers some of Trelegy Ellipta’s cost may prefer to use the Trelegy Ellipta copay card instead, while individuals without insurance might find better discounts with SingleCare.
Consider alternatives and two-inhaler treatment
Trelegy Ellipta is a three-in-one inhaler treatment, meaning it delivers fluticasone, umeclidinium, and vilanterol in every dose. “While Trelegy lacks generic equivalents due to its complex formulation, patients can explore generic alternatives for individual components, potentially offering similar effects at lower costs,” Jung says.
This means that administering these drugs via two separate inhalers could be cheaper for some patients. Certain studies have shown three-in-one treatment to be slightly more effective and affordable, but that’s not the case for everyone. Either way, consult your healthcare provider about whether Trelegy alternatives might work for you.
Compare prices
Every pharmacy sets its own prices, and they can vary by hundreds of dollars—even within the same city. So, it’s worth calling around to see which local pharmacies offer the lowest prices. Even if it means driving a few miles out of the way, the savings might be well worth it.
Trelegy insurance coverage
Insurance is often the first route people take when they want to save money on medications.
Trelegy Ellipta’s manufacturer, GSK, says on its website that around 46% of insurance-covered Trelegy prescriptions cost less than $20 per month, and the rest cost $86 per month, on average. However, Jung says, “Coverage for Trelegy varies depending on the patient’s insurance plan, formulary coverage, and provider policies. Some plans may fully or partially cover Trelegy, while others may require higher copayments or prior authorization.”
She encourages patients to “review their plan’s formulary to determine coverage and
consult their healthcare provider or pharmacist for assistance and information on financial assistance programs.”
Do Medicare and Medicaid cover Trelegy Ellipta?
Medicare Part A and Part B don’t come with prescription drug coverage, but Part D does. Some, but not all, Medicare Part D plans will cover Trelegy Ellipta. GSK says that 78.4% of Medicare-covered Trelegy Ellipta prescriptions cost less than $50 per month, and the rest cost an average of $182 per month. But, like with private health insurance, it depends on the particular plan, and those out-of-pocket costs may change throughout the year.
Medicaid requirements vary by state, but the GSK website says those who qualify pay around $4–$9 per month for Trelegy. “They may, however, have to complete prior authorization requirements to receive assistance,” says Benjamin Gibson, Pharm.D., a pharmacist, speaker, and medical writer.
Sources
- Learn about COPD, American Lung Association (2024)
- Asthma trends and burden, American Lung Association
- GSK patient assistance program for prescription medicines eligibility and enrollment, GSK
- GSK patient assistance program non-vaccine application, GSK
- Trelegy savings & coupon, GSK (2023)
- Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: Lung function and health status results from two replicate randomized controlled trials, Respiratory Research (2020)
- Impact of single combination inhaler versus multiple inhalers to deliver the same medications for patients with asthma or COPD: A systematic literature review, International Journal of Chronic Obstructive Pulmonary Disease (2020)
- GSK pricing information, GSK (2024)